About Minerva Imaging

Minerva Imaging is an integrated CRO and CDMO specialized in targeted radionuclide therapies. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.

Our competences build on more than two decades of research within oncology and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.

Contact us.

Senior Management

Carsten H. Nielsen, PhD

CEO, Co-founder

Max Damborg, MSc

CFO

Gitte Hansen, MSc

COO

Jens Skriver, MSc

CEnO

Head of CRO

Ian Wilson, PhD

Head of Partnering & Business Strategy

Head of CDMO

Camilla Christensen, MSc

Head of CDMO and R&D Radiochemistry

Board of Directors

Patrik Olof Dahlen

Chairman

Elisabeth Linnea Edith Boestad

Member

Maximilian Buchner

Member

Jonas Wilhelm Agnblad

Member

Andreas Kjaer, Prof., MD, PhD, DMSc

Member, Co-founder

Carsten H. Nielsen, PhD

Member, Co-founder

Join us

We are continuously looking for motivated and skilled people. Click here to see our current open positions.